enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO)

42 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value per share as of Q1 2024.
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,643,857 shares of 20,250,000 outstanding shares and own 18% of the company stock.
Largest 10 shareholders include KINGDON CAPITAL MANAGEMENT, L.L.C. (653,870 shares), PERCEPTIVE ADVISORS LLC (623,315 shares), VANGUARD GROUP INC (573,955 shares), Nantahala Capital Management, LLC (495,736 shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (226,308 shares), ADAR1 Capital Management, LLC (201,728 shares), Velan Capital Investment Management LP (172,235 shares), GEODE CAPITAL MANAGEMENT, LLC (137,456 shares), MORGAN STANLEY (97,550 shares), and CITADEL ADVISORS LLC (45,561 shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.